MedTrace Logo

Randomised, Controlled Trial of an Individual Deprescribing Intervention for Nursing Homes Residents

NCT03655405 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2021-05-19

Study results available
· View outcomes & findings →

Summary

This study will evaluate the effects of a pharmacist-led, deprescribing-focused medication review on the use of inappropriate medications by nursing home residents

Conditions

  • Polypharmacy
  • Inappropriate Prescribing

Interventions

OTHER

Individual Deprescribing Intervention

The pharmacist responsible for the nursing home will perform a medication review (type 3). The results of this review will be discussed with the physician and nurse responsible for this participant, with the goal of creating a personalised deprescribing plan. Once validated by the physician, this plan will be submitted to the participant for approval.

Sponsors & Collaborators

  • Anne Niquille

    lead OTHER

Principal Investigators

  • Olivier Bugnon, Prof · ISPSO, Universties of Geneva and Lausanne, Switzerland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-30
Primary Completion
2019-08-22
Completion
2019-08-22

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03655405 on ClinicalTrials.gov